Detailed answers about KAILAI PHARMACEUTICAL CO., LIMITED, including incorporation, status, business activity, and accounts information.
When was KAILAI PHARMACEUTICAL CO., LIMITED founded?
KAILAI PHARMACEUTICAL CO., LIMITED was officially incorporated on 27 May 2025 and is registered under company number 16475588. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KAILAI PHARMACEUTICAL CO., LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KAILAI PHARMACEUTICAL CO., LIMITED?
KAILAI PHARMACEUTICAL CO., LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KAILAI PHARMACEUTICAL CO., LIMITED do?
KAILAI PHARMACEUTICAL CO., LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 46750 - Wholesale of chemical products, 46760 - Wholesale of other intermediate products, 46900 - Non-specialised wholesale trade. These SIC codes provide insight into the company's business activities and industry focus.
What is KAILAI PHARMACEUTICAL CO., LIMITED's registered address?
The registered office address of KAILAI PHARMACEUTICAL CO., LIMITED is SUITE 302, 4 STATION SQUARE, CAMBRIDGE, UNITED KINGDOM, CB1 2GE. This is the official address filed with Companies House for legal and statutory correspondence.
Is KAILAI PHARMACEUTICAL CO., LIMITED financially stable?
Financial accounts for KAILAI PHARMACEUTICAL CO., LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.